ASCO GU 2024: Updates in the Treatment of Advanced Renal Cell Carcinoma - Episode 12
Focusing on belzutifan, Laurence Albigès, MD, PhD, reviews data from the LITESPARK-005 clinical trial, and Martin H. Voss, MD, discusses the ongoing LITESPARK-011 trial.